MPP+ Iodide |
An active metabolite of MPTP, a neurotoxin used to cause selective destruc… |
250 mg |
16958-250 |
More Info
|
MPP+ Iodide |
An active metabolite of MPTP, a neurotoxin used to cause selective destruc… |
50 mg |
16958-50 |
More Info
|
MPP-PICA |
An analytical reference standard that is structurally similar to known syn… |
1 mg |
31268-1 |
More Info
|
MPP-PICA |
An analytical reference standard that is structurally similar to known syn… |
5 mg |
31268-5 |
More Info
|
Mpro Inhibitor 11b |
An inhibitor of Mpro (IC50 = 0.04 µM in a TR-FRET assay); reduces vi… |
1 mg |
31345-1 |
More Info
|
Mpro Inhibitor 11b |
An inhibitor of Mpro (IC50 = 0.04 µM in a TR-FRET assay); reduces vi… |
10 mg |
31345-10 |
More Info
|
Mpro Inhibitor 11b |
An inhibitor of Mpro (IC50 = 0.04 µM in a TR-FRET assay); reduces vi… |
5 mg |
31345-5 |
More Info
|
Mps1-IN-1 |
A selective inhibitor of Mps1 kinase (IC50 = 367 nM); disrupts the recruit… |
1 mg |
19175-1 |
More Info
|
Mps1-IN-1 |
A selective inhibitor of Mps1 kinase (IC50 = 367 nM); disrupts the recruit… |
10 mg |
19175-10 |
More Info
|
Mps1-IN-1 |
A selective inhibitor of Mps1 kinase (IC50 = 367 nM); disrupts the recruit… |
5 mg |
19175-5 |
More Info
|
Mps1-IN-1 |
A selective inhibitor of Mps1 kinase (IC50 = 367 nM); disrupts the recruit… |
500 µg |
19175-500 |
More Info
|
Mps1-IN-2 |
An inhibitor of Mps1 (IC50 = 145 nM); 1,000-fold selective for Mps1 over a… |
1 mg |
19401-1 |
More Info
|
Mps1-IN-2 |
An inhibitor of Mps1 (IC50 = 145 nM); 1,000-fold selective for Mps1 over a… |
10 mg |
19401-10 |
More Info
|
Mps1-IN-2 |
An inhibitor of Mps1 (IC50 = 145 nM); 1,000-fold selective for Mps1 over a… |
25 mg |
19401-25 |
More Info
|
Mps1-IN-2 |
An inhibitor of Mps1 (IC50 = 145 nM); 1,000-fold selective for Mps1 over a… |
5 mg |
19401-5 |
More Info
|
Mps1/TTK Inhibitor |
An inhibitor of Mps1 / TTK (IC50 = 5.8 nM); inhibits Mps1 phosphorylation… |
1 mg |
25554-1 |
More Info
|
Mps1/TTK Inhibitor |
An inhibitor of Mps1 / TTK (IC50 = 5.8 nM); inhibits Mps1 phosphorylation… |
10 mg |
25554-10 |
More Info
|
Mps1/TTK Inhibitor |
An inhibitor of Mps1 / TTK (IC50 = 5.8 nM); inhibits Mps1 phosphorylation… |
25 mg |
25554-25 |
More Info
|
Mps1/TTK Inhibitor |
An inhibitor of Mps1 / TTK (IC50 = 5.8 nM); inhibits Mps1 phosphorylation… |
5 mg |
25554-5 |
More Info
|
MPT0B014 |
A tubulin polymerization inhibitor; inhibits proliferation of A549, H1299,… |
1 mg |
21718-1 |
More Info
|
MPT0B014 |
A tubulin polymerization inhibitor; inhibits proliferation of A549, H1299,… |
10 mg |
21718-10 |
More Info
|
MPT0B014 |
A tubulin polymerization inhibitor; inhibits proliferation of A549, H1299,… |
25 mg |
21718-25 |
More Info
|
MPT0B014 |
A tubulin polymerization inhibitor; inhibits proliferation of A549, H1299,… |
5 mg |
21718-5 |
More Info
|
MR2938 |
An AChE inhibitor (IC50 = 5.04 µM); selective for AChE over BChE (IC… |
1 mg |
39035-1 |
More Info
|
MR2938 |
An AChE inhibitor (IC50 = 5.04 µM); selective for AChE over BChE (IC… |
10 mg |
39035-10 |
More Info
|
MR2938 |
An AChE inhibitor (IC50 = 5.04 µM); selective for AChE over BChE (IC… |
5 mg |
39035-5 |
More Info
|
MR1/β2-Microglobulin Complex (human, recombinant) |
Source: Recombinant human MR1 and β2-microglobulin expressed in E. co… |
20 µg |
30585-20 |
More Info
|
MRE-269 |
A stable analogue of prostacyclin that potently and selectively activates… |
1 mg |
10010412-1 |
More Info
|
MRE-269 |
A stable analogue of prostacyclin that potently and selectively activates… |
10 mg |
10010412-10 |
More Info
|
MRE-269 |
A stable analogue of prostacyclin that potently and selectively activates… |
5 mg |
10010412-5 |
More Info
|
MRE-269 |
A stable analogue of prostacyclin that potently and selectively activates… |
50 mg |
10010412-50 |
More Info
|
MreB Perturbing Compound A22 |
A benzylisothiourea compound that interacts with the ATP binding site of M… |
10 mg |
15870-10 |
More Info
|
MreB Perturbing Compound A22 |
A benzylisothiourea compound that interacts with the ATP binding site of M… |
25 mg |
15870-25 |
More Info
|
MreB Perturbing Compound A22 |
A benzylisothiourea compound that interacts with the ATP binding site of M… |
50 mg |
15870-50 |
More Info
|
MR1 Immunoaffinity Sorbent |
Consists of Cayman's MR1 monoclonal antibody coupled to CNBr-activated Sep… |
400 µL |
38215-400 |
More Info
|
MRK-016 |
An inverse agonist of α5 subunit-containing GABAA receptors; selecti… |
1 mg |
36656-1 |
More Info
|
MRK-016 |
An inverse agonist of α5 subunit-containing GABAA receptors; selecti… |
10 mg |
36656-10 |
More Info
|
MRK-016 |
An inverse agonist of α5 subunit-containing GABAA receptors; selecti… |
25 mg |
36656-25 |
More Info
|
MRK-016 |
An inverse agonist of α5 subunit-containing GABAA receptors; selecti… |
5 mg |
36656-5 |
More Info
|
MRK-560 |
A potent inhibitor of γ-secretase (IC50 = 0.65 nM); reduces diethano… |
1 mg |
27599-1 |
More Info
|
MRK-560 |
A potent inhibitor of γ-secretase (IC50 = 0.65 nM); reduces diethano… |
5 mg |
27599-5 |
More Info
|
MRS1523 |
An adenosine A3 receptor antagonist; binds to the human adenosine A3 recep… |
1 mg |
17128-1 |
More Info
|
MRS1523 |
An adenosine A3 receptor antagonist; binds to the human adenosine A3 recep… |
10 mg |
17128-10 |
More Info
|
MRS1523 |
An adenosine A3 receptor antagonist; binds to the human adenosine A3 recep… |
25 mg |
17128-25 |
More Info
|
MRS1523 |
An adenosine A3 receptor antagonist; binds to the human adenosine A3 recep… |
5 mg |
17128-5 |
More Info
|
MRS1706 |
A selective adenosine A2B receptor inverse agonist (Ki = 1.39 nM) |
1 mg |
17417-1 |
More Info
|
MRS1706 |
A selective adenosine A2B receptor inverse agonist (Ki = 1.39 nM) |
10 mg |
17417-10 |
More Info
|
MRS1706 |
A selective adenosine A2B receptor inverse agonist (Ki = 1.39 nM) |
5 mg |
17417-5 |
More Info
|
MRS1706 |
A selective adenosine A2B receptor inverse agonist (Ki = 1.39 nM) |
50 mg |
17417-50 |
More Info
|
MRS1754 |
An adenosine A2B receptor antagonist (Ki = 1.97 nM); selective for adenosi… |
10 mg |
33501-10 |
More Info
|
MRS1754 |
An adenosine A2B receptor antagonist (Ki = 1.97 nM); selective for adenosi… |
25 mg |
33501-25 |
More Info
|
MRS1754 |
An adenosine A2B receptor antagonist (Ki = 1.97 nM); selective for adenosi… |
5 mg |
33501-5 |
More Info
|
MRS1754 |
An adenosine A2B receptor antagonist (Ki = 1.97 nM); selective for adenosi… |
50 mg |
33501-50 |
More Info
|
MRS1845 |
An inhibitor of SOC channels (IC50 = 1.7 µM in HL-60 leukemia cells)… |
1 mg |
36814-1 |
More Info
|
MRS1845 |
An inhibitor of SOC channels (IC50 = 1.7 µM in HL-60 leukemia cells)… |
10 mg |
36814-10 |
More Info
|
MRS1845 |
An inhibitor of SOC channels (IC50 = 1.7 µM in HL-60 leukemia cells)… |
5 mg |
36814-5 |
More Info
|
MRS1845 |
An inhibitor of SOC channels (IC50 = 1.7 µM in HL-60 leukemia cells)… |
500 µg |
36814-500 |
More Info
|
MRS2578 |
A selective antagonist of the purinergic P2Y6 receptor (IC50s = 37 and 98… |
10 mg |
19704-10 |
More Info
|
MRS2578 |
A selective antagonist of the purinergic P2Y6 receptor (IC50s = 37 and 98… |
25 mg |
19704-25 |
More Info
|
MRS2578 |
A selective antagonist of the purinergic P2Y6 receptor (IC50s = 37 and 98… |
5 mg |
19704-5 |
More Info
|
MRS2578 |
A selective antagonist of the purinergic P2Y6 receptor (IC50s = 37 and 98… |
50 mg |
19704-50 |
More Info
|
MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
1 mg |
10011450-1 |
More Info
|
MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
10 mg |
10011450-10 |
More Info
|
MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
5 mg |
10011450-5 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
1 mg |
22138-1 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
10 mg |
22138-10 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
25 mg |
22138-25 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
5 mg |
22138-5 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
1 mg |
19905-1 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
10 mg |
19905-10 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
25 mg |
19905-25 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
5 mg |
19905-5 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
1 mg |
19916-1 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
10 mg |
19916-10 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
25 mg |
19916-25 |
More Info
|